Literature DB >> 19962493

Pathophysiology of fibromyalgia.

Laurence A Bradley1.   

Abstract

This article reviews the biologic, genetic, and environmental factors that may contribute to the pathophysiology of fibromyalgia. As an affective spectrum disorder, fibromyalgia may share these causal factors with a number of related and co-occurring pain conditions, such as irritable bowel syndrome or temporomandibular disorder. There is strong evidence that cardinal pain symptoms of fibromyalgia may be due to alterations in central processing of sensory input, along with aberrations in the endogenous inhibition of pain. Genetic research has shown familial aggregation of fibromyalgia and other related disorders such as major depressive disorder. Exposure to physical or psychosocial stressors, as well as abnormal biologic responses in the autonomic nervous system and neuroendocrine responses, may also contribute to dysfunctional pain processing. As fibromyalgia research continues to progress, it is expected that the pathophysiology of this disorder will be further elucidated, leading to more rational and targeted strategies for the treatment of patients with this condition. (c) 2009 Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19962493      PMCID: PMC2821819          DOI: 10.1016/j.amjmed.2009.09.008

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  65 in total

1.  Characterization and consequences of pain variability in individuals with fibromyalgia.

Authors:  Richard E Harris; David A Williams; Samuel A McLean; Ananda Sen; Michael Hufford; R Michael Gendreau; Richard H Gracely; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2005-11

2.  Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Kanokporn Bhalang; Inna Belfer; Mitchell B Max; David Goldman; William Maixner
Journal:  Pain       Date:  2006-07-11       Impact factor: 6.961

3.  Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis.

Authors:  M C Davis; A J Zautra; J W Reich
Journal:  Ann Behav Med       Date:  2001

4.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis.

Authors:  G A McCain; K S Tilbe
Journal:  J Rheumatol Suppl       Date:  1989-11

5.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.

Authors:  Savaş Gürsoy; Emin Erdal; Hasan Herken; Ercan Madenci; Belgin Alaşehirli; Nurten Erdal
Journal:  Rheumatol Int       Date:  2002-10-22       Impact factor: 2.631

6.  Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men.

Authors:  P N Prinz; K E Moe; E M Dulberg; L H Larsen; M V Vitiello; B Toivola; G R Merriam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-07       Impact factor: 6.053

7.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 8.  Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition.

Authors:  Lars Arendt Nielsen; Karl G Henriksson
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-06       Impact factor: 4.098

9.  Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.

Authors:  Andrea Gail Nackley; Kai Soo Tan; Karamarie Fecho; Patrick Flood; Luda Diatchenko; William Maixner
Journal:  Pain       Date:  2006-11-07       Impact factor: 7.926

10.  Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study.

Authors:  K A Davies; G J Macfarlane; B I Nicholl; C Dickens; R Morriss; D Ray; J McBeth
Journal:  Rheumatology (Oxford)       Date:  2008-10-07       Impact factor: 7.580

View more
  72 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  Overcoming obstacles to developing new analgesics.

Authors:  Clifford J Woolf
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

3.  Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation.

Authors:  Sarah E Tague; Gwenaëlle L Clarke; Michelle K Winter; Kenneth E McCarson; Douglas E Wright; Peter G Smith
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia?

Authors:  Selda Bagis; Mehmet Karabiber; Ismet As; Lülüfer Tamer; Canan Erdogan; Ayçe Atalay
Journal:  Rheumatol Int       Date:  2012-01-22       Impact factor: 2.631

Review 5.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

Review 6.  Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.

Authors:  Sheena Derry; Philip J Wiffen; Winfried Häuser; Martin Mücke; Thomas Rudolf Tölle; Rae F Bell; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-03-27

7.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

Review 8.  Oxycodone for pain in fibromyalgia in adults.

Authors:  Helen Gaskell; R Andrew Moore; Sheena Derry; Cathy Stannard
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

9.  You get used to it, or do you: symptom length predicts less fibromyalgia physical impairment, but only for those with above-average self-efficacy.

Authors:  Charles Van Liew; Gabriel Leon; Mikayla Neese; Terry A Cronan
Journal:  Psychol Health Med       Date:  2018-09-30       Impact factor: 2.423

10.  Pain reporting at different body sites is explained by a single underlying genetic factor.

Authors:  Frances M K Williams; Tim D Spector; Alex J MacGregor
Journal:  Rheumatology (Oxford)       Date:  2010-06-04       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.